肿瘤伴中性粒细胞减少疑似感染患者的体温轨迹亚表型
这项回顾性两医院研究分析了肿瘤伴中性粒细胞减少疑似感染成人患者,用既往验证的模型将入院最初72小时体温轨迹分为四个亚表型,用多因素模型分析其与住院死亡和血流感染的独立关系。主要队列1145例、验证队列6564例。高热缓慢消退型、低体温型死亡率高于高热快速消退型和正常体温型(P<0.001),血流感染在高热缓慢消退型和高热快速消退型更常见(P<0.001)。校正混杂后高热缓慢消退型死亡和血流感染的校正比值比均升高。
要点
- 四个体温轨迹亚表型:高热缓慢消退型占14.8%、死亡9.1%;低体温型占20.9%、死亡8.6%;高热快速消退型占17.0%、死亡3.6%;正常体温型占47.3%、死亡5.4%(P<0.001)。
- 血流感染:高热缓慢消退型21.8%、高热快速消退型18.3%,高于低体温型11.7%和正常体温型11.5%(P<0.001)。
- 校正混杂后高热缓慢消退型死亡校正OR:主要队列1.91(P=0.03),验证队列2.19(P<0.001)。
- 校正混杂后高热缓慢消退型血流感染校正OR:主要队列1.54(P=0.04),验证队列2.15(P<0.001)。
适用人群与场景
- 成人肿瘤住院患者,伴中性粒细胞减少且在24小时内留取血培养。
研究设计与关键结果
- 回顾性两医院研究,主要队列n=1145,验证队列n=6564。
- 采用既往验证的模型将入院最初72小时体温轨迹分为四个亚表型。
- 高热缓慢消退型(合并n=1140,14.8%)死亡n=104(9.1%);低体温型(n=1612,20.9%)死亡n=138(8.6%);高热快速消退型(n=1314,17.0%)死亡n=47(3.6%);正常体温型(n=3643,47.3%)死亡n=196(5.4%)(P<0.001)。
- 血流感染:高热缓慢消退型n=248(21.8%),高热快速消退型n=240(18.3%),低体温型n=188(11.7%),正常体温型n=418(11.5%)(P<0.001)。
- 校正混杂后高热缓慢消退型死亡校正OR:主要队列1.91(P=0.03),验证队列2.19(P<0.001)。
- 校正混杂后高热缓慢消退型血流感染校正OR:主要队列1.54(P=0.04),验证队列2.15(P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性两医院队列研究。
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Despite etiologic and severity heterogeneity in neutropenic sepsis, management is often uniform. Understanding host response clinical subphenotypes might inform treatment strategies for neutropenic sepsis. Objectives: In this retrospective two-hospital study, we analyzed whether temperature trajectory modeling could identify distinct, clinically relevant subphenotypes among oncology patients with neutropenia and suspected infection. Methods: Among adult oncologic admissions with neutropenia and blood cultures within 24 hours, a previously validated model classified patients' initial 72-hour temperature trajectories into one of four subphenotypes. We analyzed subphenotypes' independent relationships with hospital mortality and bloodstream infection using multivariable models. Measurements and Main Results: Patients (primary cohort n = 1,145, validation cohort n = 6,564) fit into one of four temperature subphenotypes. "Hyperthermic slow resolvers" (pooled n = 1,140 [14.8%], mortality n = 104 [9.1%]) and "hypothermic" encounters (n = 1,612 [20.9%], mortality n = 138 [8.6%]) had higher mortality than "hyperthermic fast resolvers" (n = 1,314 [17.0%], mortality n = 47 [3.6%]) and "normothermic" (n = 3,643 [47.3%], mortality n = 196 [5.4%]) encounters (P < 0.001). Bloodstream infections were more common among hyperthermic slow resolvers (n = 248 [21.8%]) and hyperthermic fast resolvers (n = 240 [18.3%]) than among hypothermic (n = 188 [11.7%]) or normothermic (n = 418 [11.5%]) encounters (P < 0.001). Adjusted for confounders, hyperthermic slow resolvers had increased adjusted odds for mortality (primary cohort odds ratio, 1.91 [P = 0.03]; validation cohort odds ratio, 2.19 [P < 0.001]) and bloodstream infection (primary odds ratio, 1.54 [P = 0.04]; validation cohort odds ratio, 2.15 [P < 0.001]). Conclusions: Temperature trajectory subphenotypes were independently associated with important outcomes among hospitalized patients with neutropenia in two independent cohorts.
参考来源
- Benzoni NS, Carey KA, Bewley AF, et al. Temperature Trajectory Subphenotypes in Oncology Patients with Neutropenia and Suspected Infection. Am J Respir Crit Care Med. 2023. PMID: 36449534. doi:10.1164/rccm.202205-0920OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。